Secondary aims included determining: (i) the risk factors for the development of RSVbronchiolitis; (ii) the fatality rates and risk factors associated with mortality; (iii) the correlation with c-reactive protein values and risk ofcomorbid bacterial infection; and (iv) the impact of seasonality on RSV incidence. This evidence concerns the gene CRP and bacterial infectious disease.